29.69
price up icon12.38%   3.27
after-market Handel nachbörslich: 30.50 0.81 +2.73%
loading
Schlusskurs vom Vortag:
$26.42
Offen:
$26.95
24-Stunden-Volumen:
1.38M
Relative Volume:
0.94
Marktkapitalisierung:
$915.42M
Einnahmen:
$117.67M
Nettoeinkommen (Verlust:
$-1.88B
KGV:
-0.4904
EPS:
-60.5369
Netto-Cashflow:
$-621.36M
1W Leistung:
+14.48%
1M Leistung:
-1.98%
6M Leistung:
+108.06%
1J Leistung:
+0.00%
1-Tages-Spanne:
Value
$26.75
$29.87
1-Wochen-Bereich:
Value
$25.12
$29.87
52-Wochen-Spanne:
Value
$12.33
$63.99

Grail Inc Stock (GRAL) Company Profile

Name
Firmenname
Grail Inc
Name
Telefon
(833) 694-2553
Name
Adresse
1525 O'BRIEN DRIVE, MENLO PARK
Name
Mitarbeiter
1,000
Name
Twitter
Name
Nächster Verdiensttermin
2024-11-12
Name
Neueste SEC-Einreichungen
Name
GRAL's Discussions on Twitter

Vergleichen Sie GRAL mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Diagnostics & Research icon
GRAL
Grail Inc
29.69 915.42M 117.67M -1.88B -621.36M -60.54
Diagnostics & Research icon
TMO
Thermo Fisher Scientific Inc
434.73 166.47B 42.88B 6.34B 7.27B 16.53
Diagnostics & Research icon
DHR
Danaher Corp
192.07 135.88B 23.88B 3.90B 5.30B 5.28
Diagnostics & Research icon
IDXX
Idexx Laboratories Inc
421.59 32.74B 3.90B 887.87M 798.08M 10.67
Diagnostics & Research icon
A
Agilent Technologies Inc
102.81 29.40B 6.53B 1.26B 1.31B 4.35
Diagnostics & Research icon
IQV
Iqvia Holdings Inc
143.61 26.30B 15.41B 1.37B 2.11B 7.50

Grail Inc Stock (GRAL) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2024-11-27 Eingeleitet Morgan Stanley Equal-Weight
2024-11-15 Eingeleitet Wolfe Research Peer Perform
2024-10-17 Eingeleitet Guggenheim Neutral

Grail Inc Aktie (GRAL) Neueste Nachrichten

pulisher
04:01 AM

GRAIL to Present New Data on Galleri® and its Methylation Platform at American Association for Cancer Research (AACR) Annual Meeting - PR Newswire

04:01 AM
pulisher
12:09 PM

Quest Diagnostics Revenue Rebound, Strategic Moves Fuel Outlook Confidence - Benzinga

12:09 PM
pulisher
02:55 AM

Opinion | The FTC vs. the War on Cancer - WSJ

02:55 AM
pulisher
Apr 21, 2025

This Cancer Test Could Become Routine—and a Big Seller, Says Analyst - Barron's

Apr 21, 2025
pulisher
Apr 21, 2025

Canaccord sets $32 target on GRAIL stock with buy rating By Investing.com - Investing.com Nigeria

Apr 21, 2025
pulisher
Apr 21, 2025

Canaccord starts Grail with a Buy, sees ‘solid upside’ - TipRanks

Apr 21, 2025
pulisher
Apr 21, 2025

Canaccord Genuity Initiates GRAIL at Buy With $32 Price Target - marketscreener.com

Apr 21, 2025
pulisher
Apr 21, 2025

Canaccord sets $32 target on GRAIL stock with buy rating - Investing.com Australia

Apr 21, 2025
pulisher
Apr 16, 2025

GRAIL, Inc. (GRAL): A Bull Case Theory - Insider Monkey

Apr 16, 2025
pulisher
Apr 16, 2025

Form DEF 14A GRAIL, Inc. For: May 29 - StreetInsider

Apr 16, 2025
pulisher
Apr 12, 2025

GRAIL's Galleri Progresses While Back In Accumulation Levels - Seeking Alpha

Apr 12, 2025
pulisher
Apr 09, 2025

AI-Powered Studio GRAiL Launched By Davide Bianca & Jeff Krelitz - Deadline

Apr 09, 2025
pulisher
Apr 08, 2025

How Does GRAIL Benefit From The Proposed MCED Legislation? (NASDAQ:GRAL) - Seeking Alpha

Apr 08, 2025
pulisher
Apr 06, 2025

Multi-Cancer Early Detection Market Critical Analysis with Expert Opinion| GRAIL, Natera, Elypta - openPR.com

Apr 06, 2025
pulisher
Mar 31, 2025

Jim Cramer Likes GRAIL, Inc. (GRAL) Despite Losses – Great Science, Risky Bet! - Yahoo Finance

Mar 31, 2025
pulisher
Mar 29, 2025

Illumina to buy Jeff Bezos-backed cancer testing firm Grail in $8 billion deal - MarketScreener

Mar 29, 2025
pulisher
Mar 27, 2025

A Sydney company’s laser focus on energy’s holy grail - @AuManufacturing

Mar 27, 2025
pulisher
Mar 25, 2025

Opinion | One ‘Monopoly’ That Could Save Your Life - The Wall Street Journal

Mar 25, 2025
pulisher
Mar 21, 2025

Is GRAIL Stock About to Skyrocket? - timothysykes.com

Mar 21, 2025
pulisher
Mar 20, 2025

GRAIL Careers, Perks + Culture - Built In

Mar 20, 2025
pulisher
Mar 19, 2025

Debate Over Multi-Cancer Screening Tests Shifts Pending Grail Randomized Trial Results - GenomeWeb

Mar 19, 2025
pulisher
Mar 18, 2025

FDA approval remains Holy Grail for Aussie biotechs - NT News

Mar 18, 2025
pulisher
Mar 18, 2025

Biocurious: FDA approval remains the Holy Grail for ASX life science stocks - Stockhead

Mar 18, 2025
pulisher
Mar 18, 2025

Grail price target raised to $20 from $16 at Morgan Stanley - TipRanks

Mar 18, 2025
pulisher
Mar 16, 2025

Have Insiders Sold GRAIL Shares Recently? - Simply Wall St

Mar 16, 2025
pulisher
Mar 16, 2025

Jim Cramer On Netflix, Inc. (NFLX) – Subscription Is the Holy Grail—Netflix Is Doing Very Well! - Insider Monkey

Mar 16, 2025
pulisher
Mar 16, 2025

Illumina Wins Court Fight With EU Over $7 Billion Grail Deal - MSN

Mar 16, 2025
pulisher
Mar 13, 2025

Grail president Joshua Ofman sells $65,800 in common stock By Investing.com - Investing.com Australia

Mar 13, 2025
pulisher
Mar 12, 2025

Grail CEO Robert Ragusa sells $237,976 in stock By Investing.com - Investing.com Canada

Mar 12, 2025
pulisher
Mar 12, 2025

Grail CEO Robert Ragusa sells $237,976 in stock - Investing.com India

Mar 12, 2025
pulisher
Mar 12, 2025

Grail president Joshua Ofman sells $65,800 in common stock - Investing.com

Mar 12, 2025
pulisher
Mar 10, 2025

Oppenheimer & Co. Inc. Invests $190,000 in Grail, Inc. (NASDAQ:GRAL) - Defense World

Mar 10, 2025
pulisher
Mar 09, 2025

Rhumbline Advisers Makes New Investment in Grail, Inc. (NASDAQ:GRAL) - Defense World

Mar 09, 2025
pulisher
Mar 07, 2025

New York State Common Retirement Fund Makes New $59,000 Investment in Grail, Inc. (NASDAQ:GRAL) - Defense World

Mar 07, 2025
pulisher
Mar 04, 2025

Grail’s Stock Surge: An Eye on Future Moves - timothysykes.com

Mar 04, 2025
pulisher
Mar 03, 2025

GRALGrail Inc Latest Stock News & Market Updates - StockTitan

Mar 03, 2025
pulisher
Mar 03, 2025

Is GRAIL, Inc. (GRAL) Among Jeff Bezos’ Investments in 2025? - Yahoo Finance

Mar 03, 2025
pulisher
Mar 02, 2025

Jeff Bezos Investments in 2025: 12 Companies Bezos Is Investing In - Insider Monkey

Mar 02, 2025
pulisher
Feb 28, 2025

Ieq Capital LLC Acquires Shares of 19,874 Grail, Inc. (NASDAQ:GRAL) - MarketBeat

Feb 28, 2025
pulisher
Feb 27, 2025

Grail (NASDAQ:GRAL) Trading 9.8% HigherWhat's Next? - MarketBeat

Feb 27, 2025
pulisher
Feb 26, 2025

GRAIL Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - PR Newswire

Feb 26, 2025
pulisher
Feb 25, 2025

Grail goes ‘Grey’s’: Actor Kate Walsh joins awareness campaign for multi-cancer early detection testing - FiercePharma

Feb 25, 2025
pulisher
Feb 25, 2025

GRAIL Partners With Actress Kate Walsh for Generation Possible to Raise Awareness of Multi-Cancer Early Detection Testing - Longview News-Journal

Feb 25, 2025
pulisher
Feb 25, 2025

Grail projects FDA submission completion for Galleri by H1 2026 with expanded scalability - MSN

Feb 25, 2025
pulisher
Feb 24, 2025

GRAIL, Inc. (GRAL): Among the Best Performing Small Cap Stocks So Far In 2025 - Insider Monkey

Feb 24, 2025
pulisher
Feb 24, 2025

Why Grail (GRAL) Is Falling Today - MSN

Feb 24, 2025
pulisher
Feb 23, 2025

Van ECK Associates Corp Takes $475,000 Position in Grail, Inc. (NASDAQ:GRAL) - Defense World

Feb 23, 2025
pulisher
Feb 22, 2025

Grail initiated at equal weight by Morgan Stanley - MSN

Feb 22, 2025
pulisher
Feb 21, 2025

Can GRAIL's Cancer Detection Technology Transform Healthcare? Key Presentation Coming March 4 - StockTitan

Feb 21, 2025
pulisher
Feb 21, 2025

Putting early cancer detection to the test - Nature.com

Feb 21, 2025

Finanzdaten der Grail Inc-Aktie (GRAL)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading

Grail Inc-Aktie (GRAL) Insiderhandel

Insiderhandel Beziehung Datum Transaktion Kosten #Aktien Wert ($) #Aktien Gesamt
Ofman Joshua J.
President
Mar 07 '25
Sale
31.20
2,109
65,801
559,673
Freidin Aaron
Chief Financial Officer
Mar 07 '25
Sale
31.20
1,816
56,659
335,170
diagnostics_research DGX
$172.84
price up icon 6.78%
diagnostics_research LH
$220.25
price up icon 3.78%
diagnostics_research WAT
$330.71
price up icon 4.58%
$144.62
price up icon 1.68%
diagnostics_research MTD
$1,003.16
price up icon 3.40%
diagnostics_research IQV
$143.61
price up icon 1.69%
Kapitalisierung:     |  Volumen (24h):